BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27377421)

  • 1. Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.
    Cereda M; Gambardella G; Benedetti L; Iannelli F; Patel D; Basso G; Guerra RF; Mourikis TP; Puccio I; Sinha S; Laghi L; Spencer J; Rodriguez-Justo M; Ciccarelli FD
    Nat Commun; 2016 Jul; 7():12072. PubMed ID: 27377421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic plasticity and genetic control in colorectal cancer evolution.
    Househam J; Heide T; Cresswell GD; Spiteri I; Kimberley C; Zapata L; Lynn C; James C; Mossner M; Fernandez-Mateos J; Vinceti A; Baker AM; Gabbutt C; Berner A; Schmidt M; Chen B; Lakatos E; Gunasri V; Nichol D; Costa H; Mitchinson M; Ramazzotti D; Werner B; Iorio F; Jansen M; Caravagna G; Barnes CP; Shibata D; Bridgewater J; Rodriguez-Justo M; Magnani L; Sottoriva A; Graham TA
    Nature; 2022 Nov; 611(7937):744-753. PubMed ID: 36289336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.
    Benedetti L; Cereda M; Monteverde L; Desai N; Ciccarelli FD
    Oncotarget; 2017 Jun; 8(23):37619-37632. PubMed ID: 28430577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEGA-V: detection of variant gene sets in patient cohorts.
    Gambardella G; Cereda M; Benedetti L; Ciccarelli FD
    Bioinformatics; 2017 Apr; 33(8):1248-1249. PubMed ID: 28003259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
    Vanni I; Pastorino L; Andreotti V; Comandini D; Fornarini G; Grassi M; Puccini A; Tanda ET; Pastorino A; Martelli V; Mastracci L; Grillo F; Cabiddu F; Guadagno A; Coco S; Allavena E; Barbero F; Bruno W; Dalmasso B; Bellomo SE; Marchiò C; Spagnolo F; Sciallero S; Berrino E; Ghiorzo P
    J Transl Med; 2024 May; 22(1):462. PubMed ID: 38750555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome.
    Yang LP; Jiang TJ; He MM; Ling YH; Wang ZX; Wu HX; Zhang Z; Xu RH; Wang F; Yuan SQ; Zhao Q
    Cell Rep Med; 2023 Oct; 4(10):101222. PubMed ID: 37794586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer.
    Greco L; Rubbino F; Dal Buono A; Laghi L
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of the Prognostic Significance of CAND1 in ERα-Positive Breast Cancer.
    Alhammad R
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 regulates alternative splicing in prostate cancer.
    Del Giudice M; Foster JG; Peirone S; Rissone A; Caizzi L; Gaudino F; Parlato C; Anselmi F; Arkell R; Guarrera S; Oliviero S; Basso G; Rajan P; Cereda M
    Cell Rep; 2022 Sep; 40(13):111404. PubMed ID: 36170835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer.
    Alhammad R
    Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer.
    Cao L; Li T; Ba Y; Chen E; Yang J; Zhang H
    Front Genet; 2022; 13():801484. PubMed ID: 35281839
    [No Abstract]   [Full Text] [Related]  

  • 12. Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors.
    Berrino E; Filippi R; Visintin C; Peirone S; Fenocchio E; Farinea G; Veglio F; Aglietta M; Sapino A; Cereda M; Visintin R; Pasini B; Marchiò C
    NPJ Precis Oncol; 2022 Mar; 6(1):15. PubMed ID: 35260767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Genomic Analysis Reveals Heterogeneity Between Lesions in Synchronous Primary Right-Sided and Left-Sided Colon Cancer.
    Perea J; Corchete L; García JL; Urioste M; González-Sarmiento R
    Front Mol Biosci; 2021; 8():803707. PubMed ID: 35127822
    [No Abstract]   [Full Text] [Related]  

  • 14. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
    Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
    BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial to Mesenchymal Transition: A Challenging Playground for Translational Research. Current Models and Focus on
    Greco L; Rubbino F; Morelli A; Gaiani F; Grizzi F; de'Angelis GL; Malesci A; Laghi L
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of a patient with quadruple synchronous colorectal cancer: a case report.
    Jia X; Peng X; Sun J; Zhang T; Lin H; Bai T; Zhang A
    BMC Gastroenterol; 2021 Oct; 21(1):360. PubMed ID: 34600484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Analysis Reveals Heterogeneity Between Lesions in Synchronous Primary Right-Sided and Left-Sided Colon Cancer.
    Hu H; Zhang Q; Huang R; Gao Z; Yuan Z; Tang Q; Gao F; Wang M; Zhang W; Ma T; Qiao T; Jin Y; Wang G
    Front Mol Biosci; 2021; 8():689466. PubMed ID: 34422903
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial Intelligence in Bulk and Single-Cell RNA-Sequencing Data to Foster Precision Oncology.
    Del Giudice M; Peirone S; Perrone S; Priante F; Varese F; Tirtei E; Fagioli F; Cereda M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
    Wen S; He L; Zhong Z; Mi H; Liu F
    Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a prognostic signature for bladder cancer based on immune-related genes.
    Shi YR; Xiong K; Ye X; Yang P; Wu Z; Zu XB
    Ann Transl Med; 2020 Nov; 8(21):1380. PubMed ID: 33313125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.